Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The key objectives of this study are to determine, using sleep diaries, whether lemborexant at the doses 5 milligrams (mg) and 10 mg is superior to placebo on subjective sleep onset, subjective sleep efficiency, and subjective sleep maintenance in participants with insomnia disorder.
Epistemonikos ID: 36ac084e0211e16ee5258d6a8cc112f983dcd7bc
First added on: May 17, 2024